Q&A - Make Medicines Affordable

Supporting more people to challenge injustices: A day in the life of a treatment activist

6 Sep 2019

Interview Q&A

What got you interested in treatment activism to start with? Someone in my family was struggling to access life-saving medicines....

FAQs for women of childbearing potential and dolutegravir: Key interim considerations

31 Oct 2018

News Q&A

A forum on the risks of preconception dolutegravir exposure has pulled together frequently asked questions (FAQs) designed to help provide...

IP-Watch Q&A with Carlos Correa: The myth of IP incentives for all nations

20 Jun 2018

Interview Q&A

Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property,...

IP-Watch Q&A with Othoman Mellouk: The myth behind health and trade agreements

19 Jun 2018

Interview Q&A

Othoman Mellouk is the Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC), and campaign...